Ready-to-Administer IV Push Products: A Multidisciplinary Approach to Safety, Cost-Effectiveness, and Patient Outcomes in Health System and Perioperative Settings

This educational activity will examine the landscape of considerations regarding ready-to-administer (RTA) IV push products compared with traditional IV vial products. The holistic costs of waste, taking into account cost-effectiveness data in the selection and implementation of RTA IV push products will also be discussed. New evidence regarding perioperative opioid use and associated adverse clinical outcomes will be presented along with strategies for reducing product waste, organizational costs, and postoperative adverse events.

Tuesday, Dec. 5
11:30 a.m. - 1 p.m. PT (2:30 - 4 p.m. ET)

Symposium Location: Room 155,100 Level, Anaheim Convention Center – North

Come early! Seating is limited and provided on a first-come, first-served basis.

Can't make it to Anaheim? Tune into the Free Live Webinar Broadcast.
Registration is required for the webinar.


John B. Hertig

John B. Hertig, PharmD, MS, CPPS, FASHP, FFIP, Activity Chair
Associate Professor and Chair Department of Pharmacy Practice
Butler University
Indianapolis, Indiana

John B. Hertig, PharmD, MS, CPPS, FASHP, FFIP is Chair and an Associate Professor of Pharmacy Practice in the Butler University College of Pharmacy and Health Sciences (Indianapolis, USA). Dr. Hertig lectures around the world and publishes on a variety of patient safety, leadership, administration, health policy topics. He serves as an Associate Editor for the Journal of Medicine Access, and his extensive research program is designed to enhance the safety of the medication use process, while using evidence to inform patient advocacy efforts. Dr. Hertig is a Member of the United States Food and Drug Administration Drug Safety and Risk Management Advisory Committee. He holds other national and international appointments, including with the International Pharmaceutical Federation, where he is Treasurer for the Hospital Pharmacy Section, and as Past-President of the Board of Directors for the Alliance for Safe Online Pharmacies – Global (ASOP), where he leads efforts to reduce the patient safety impact of illegal and counterfeit online drug distribution worldwide. He was awarded the ASOP Global Patient Safety Champion Award in 2018. Dr. Hertig received his Bachelor of Science in Pharmaceutical Sciences and Doctor of Pharmacy degrees from Purdue University (USA). He completed a PGY1 pharmacy practice and PGY2 health-system pharmacy administration residency at The Ohio State University Medical Center while also obtaining a Masters degree in Health-System Pharmacy Administration from The Ohio State University (USA).

Satya Krishna Ramachandran

Satya Krishna Ramachandran, MD
Staff Anesthesiologist, Associate Professor of Anesthesia, and Program Director, Fellowship in Perioperative Quality and Safety
Harvard Medical Faculty Physicians
Boston, Massachusetts

Satya Krishna Ramachandran, MD is an internationally recognized leader in healthcare quality and patient safety. After his early years in India, he developed his medical and leadership career at the Oxford Radcliffe hospitals, the University of Michigan, and Brandeis University. Krish is a busy clinician, educator and a widely cited researcher. He is an Assoc. Professor at Harvard Medical School, practices anesthesiology, runs a highly successful quality and safety fellowship program, and drives healthcare change through his leadership roles in Boston. Throughout his career, he has brought together diverse teams across disciplines, organizations, and continents. He is the Founding-Director of the “International Institute for Health Innovation”.

Target Audience

This activity was planned to meet the educational needs of pharmacists who practice in hospitals and health systems, including chief pharmacy officers, pharmacy leaders and administrators, medication safety and compliance officers, and procurement managers.

Learning Objectives

  • Examine peer-reviewed literature covering various use considerations for manufacturer-prepared ready-to-administer (RTA) and traditional IV vial products.
  • Discuss the holistic costs of waste, focusing on incorporating cost-effectiveness data in the selection and implementation of RTA IV push products in health-systems.
  • Interpret new evidence regarding perioperative opioid use and associated adverse clinical outcomes.
  • Identify strategies to reduce product waste, organizational costs, and postoperative adverse events.


  • 11:30 a.m. – Welcome and Introductions
    John B. Hertig
  • 11:35 a.m. – Viewing the Big Picture with Ready-to-Administer IV Push Products: Safety, Cost-Effectiveness, and Patient Outcomes
    John B. Hertig
  • 12:15 p.m. – Size Matters: Costs and Predictive Factors of Opioid Waste in the Perioperative Setting
    Satya Krishna Ramachandran
  • 12:50 p.m. – Faculty Discussion, Questions and Answers
    All Faculty

Accredited for CPE

ACPE #: 0204-0000-23-411-L04-P
CE Credit: 1.5 contact hours (0.15 CEUs)
Activity Type: Application-based
Activity Fee: No charge

To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation.



ACPE logo black and white The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
ASHP Advantage logo Provided by ASHP.
Supported by an educational grant from Fresenius Kabi USA, LLC.
For questions and assistance to participate, contact us.